Yahoo · Nov 26, 2025
BC-Most Active Stocks
td class="col-issue">Clean Energy Technologies Inc.
ZY
NASDAQ · ZYXI
Zynex, Inc.
Healthcare · Medical - Distribution
$0.13
Up+$0.07 (+140.38%)
Updated Oct 8, 2026, 4:11 AM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 26.47M
- P/E ratio
- -0.36
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 274.57K
- Avg. volume
- 4.74M
Price performance · ZYXI
ZYXI price history
1M range · 0 trading sessions · Daily adjusted prices
ZYXI does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ZYXI news
The latest Smart Investors Daily articles mentioning ZYXI.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ZYXI research
Overview
Company profile and research snapshot.
Company profile
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $14.38
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 1, 2025 | HC Wainwright & Co. | Neutral | — |
| Jul 15, 2025 | RBC Capital | Sector Perform | — |
| Jun 30, 2025 | HC Wainwright & Co. | Buy | — |
| Apr 30, 2025 | HC Wainwright & Co. | Buy | — |
| Apr 30, 2025 | RBC Capital | Sector Perform | — |
News briefing
No generated briefing is available yet.
Yahoo · Nov 18, 2025
Zynex Inc (ZYXI) Q3 2025 Earnings Call Highlights: Navigating Financial Challenges Amid ...
Despite a significant revenue drop, Zynex Inc (ZYXI) focuses on strategic alternatives and compliance improvements to stabilize its financial position.
seekingalpha.com · Nov 18, 2025
Zynex, Inc. (ZYXI) Q3 2025 Earnings Call Prepared Remarks Transcript
Zynex, Inc. ( ZYXI ) Q3 2025 Earnings Call November 18, 2025 9:00 AM EST Company Participants Vikram Bajaj - Chief Financial Officer Steven Dyson - CEO & Director Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Zynex Third Quarter 2025 Earnings Conference Call.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
